Beta-amyloid peptide (Abeta), the major constituent of amyloid plaques in the brains of Alzheimer's patients, is thought to be the cause of Alzheimer's Disease (AD). AD is the most common neurodegenerative disease and afflicts about 10% of the population over 604. Beta Amyloid 7E7 (BA-1001) is a rPeptide exclusive Beta Amyloid Monoclonal Antibody that binds Beta Amyloid 1-42 and Beta Amyloid 1-40.